
A bio-tech firm in Gaithersburg, Maryland is the first of four drug-makers to roll out an H1N1 vaccine approved by the Food and Drug Administration. MedImmune got FDA approval of its seasonal flu vaccine, FluMist, in 2003. It began developing an H1N1 vaccine in April.
Unlike the other vaccines being manufactured, MedImmune's contains a live, weakened form of the virus... sprayed into the nose. MedImmune has produced 40-million doses so far. The first batches should be available the first week of October.
Rebecca Sheir reports...

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.